NCT07116694Phase 2Completed

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

Study sponsor: BioXcel Therapeutics Inc

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-10-07Actual
Enrollment · participants33Actual
Source updated2026-10-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 30 participants (planned). After: 33 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Oct 2025. After: 7 Oct 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview